World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
92
Citations
31025
World Ranking
11308
National Ranking
215

Overview

Magnus Björkholm is affiliated with the Karolinska University Hospital in Sweden. Their research focuses primarily on hematology and oncology, with significant contributions to the fields of medicine, biochemistry, genetics, and molecular biology.

The scientist's work covers a range of topics including:

  • Lymphoma Diagnosis and Treatment
  • Chronic Lymphocytic Leukemia Research
  • Multiple Myeloma Research and Treatments
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Chronic Myeloid Leukemia Treatments
  • Acute Myeloid Leukemia Research
  • Amyloidosis: Diagnosis, Treatment, Outcomes

Magnus Björkholm has authored numerous papers, some of the recent notable publications include:

  • "Molecular features encoded in the ctDNA reveal heterogeneity and predict outcome in high-risk aggressive B-cell lymphoma," 2021, published in Blood
  • "Patients with high-risk DLBCL benefit from dose-dense immunochemotherapy combined with early systemic CNS prophylaxis," 2020, published in Blood Advances
  • "Risk of infections in patients with myeloproliferative neoplasms-a population-based cohort study of 8363 patients," 2020, published in Leukemia
  • "Incidence of myeloproliferative neoplasms - trends by subgroup and age in a population-based study in Sweden," 2020, published in Journal of Internal Medicine
  • "Comorbidities in multiple myeloma and implications on survival: A population-based study," 2021, published in European Journal Of Haematology

The frequent coauthors who have collaborated with Björkholm include:

  • Sigurður Y. Kristinsson
  • Ola Landgren
  • Ingemar Turesson
  • Malin Hultcrantz
  • Dawei Xu

Regarding publication venues, Magnus Björkholm commonly publishes in these journals:

  • European Journal Of Haematology
  • Blood
  • HemaSphere
  • Leukemia
  • Haematologica

Björkholm's work in subfields of study emphasizes:

  • Genetics
  • Hematology
  • Molecular Biology
  • Pathology and Forensic Medicine
  • Oncology

Best Publications

  • Phase II trial of subcutaneous anti-CD52 monoclonal antibody alemtuzumab (Campath-1H) as first-line treatment for patients with B-cell chronic lymphocytic leukemia (B-CLL).

    Jeanette Lundin;Eva Kimby;Magnus Björkholm;Per-Anders Broliden

  • Life Expectancy of Patients With Chronic Myeloid Leukemia Approaches the Life Expectancy of the General Population

    Hannah Bower;Magnus Björkholm;Paul W. Dickman;Martin Höglund

  • Acute myeloid leukaemia.

    Asim Khwaja;Magnus Bjorkholm;Rosemary E Gale;Ross L Levine

  • Multiple myeloma and infections: a population-based study on 9253 multiple myeloma patients.

    Cecilie Blimark;Erik Holmberg;Ulf-Henrik Mellqvist;Ola Landgren

  • Antibodies to cardiolipin in young survivors of myocardial infarction: an association with recurrent cardiovascular events

    A. Hamsten;M. Björkholm;R. Norberg;U. De Faire

  • Switch from Myc/Max to Mad1/Max binding and decrease in histone acetylation at the telomerase reverse transcriptase promoter during differentiation of HL60 cells.

    Dawei Xu;Nikita Popov;Mi Hou;Qian Wang

  • Prognostic markers and criteria to initiate therapy in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.

    Robert A. Kyle;Steven P. Treon;Raymond Alexanian;Bart Barlogie

  • Patterns of Survival in Multiple Myeloma: A Population-Based Study of Patients Diagnosed in Sweden From 1973 to 2003

    Sigurdur Yngvi Kristinsson;Ola Landgren;Paul W. Dickman;Åsa Rangert Derolf

  • INTERFERON THERAPY IN MYELOMATOSIS

    H Mellstedt;M Björkholm;B Johansson;A Ahre

  • Downregulation of telomerase reverse transcriptase mRNA expression by wild type p53 in human tumor cells

    Dawei Xu;Qian Wang;Astrid Gruber;Magnus Björkholm

  • Increased risks of polycythemia vera, essential thrombocythemia, and myelofibrosis among 24,577 first-degree relatives of 11,039 patients with myeloproliferative neoplasms in Sweden.

    Ola Landgren;Ola Landgren;Lynn R. Goldin;Sigurdur Y. Kristinsson;Elin A. Helgadottir

  • Chronic Immune Stimulation Might Act As a Trigger for the Development of Acute Myeloid Leukemia or Myelodysplastic Syndromes

    Sigurdur Y. Kristinsson;Magnus Björkholm;Malin Hultcrantz;Åsa R. Derolf

  • Risk of haematopoietic cancer in patients with inflammatory bowel disease.

    J Askling;L Brandt;A Lapidus;P Karlén

  • Treatment-Related Risk Factors for Transformation to Acute Myeloid Leukemia and Myelodysplastic Syndromes in Myeloproliferative Neoplasms

    Magnus Björkholm;Åsa R. Derolf;Malin Hultcrantz;Sigurdur Y. Kristinsson

  • Telomerase reverse transcriptase promotes epithelial–mesenchymal transition and stem cell-like traits in cancer cells

    Z Liu;Q Li;Q Li;K Li;L Chen

  • Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based study

    Sigurdur Y. Kristinsson;Ruth M. Pfeiffer;Magnus Björkholm;Lynn R. Goldin

  • Frequent patient-to-patient transmission of hepatitis C virus in a haematology ward

    T. Allander;A. Gruber;A. Beyene;M. Björkholm

  • Expression of the Epstein-Barr virus-encoded Epstein-Barr virus nuclear antigen 1 in Hodgkin's Lymphoma cells mediates Up-regulation of CCL20 and the migration of regulatory T cells

    Karl R.N. Baumforth;Anna Birgersdotter;Gary M. Reynolds;Wenbin Wei

  • Hypocholesterolaemia in malignancy due to elevated low-density-lipoprotein-receptor activity in tumour cells: evidence from studies in patients with leukaemia.

    Sigurd Vitols;Magnus Björkholm;Gösta Gahrton;Curt Peterson

  • Success Story of Targeted Therapy in Chronic Myeloid Leukemia: A Population-Based Study of Patients Diagnosed in Sweden From 1973 to 2008

    Magnus Björkholm;Lotta Ohm;Sandra Eloranta;Åsa Derolf

Frequent Co-Authors

Ola Landgren
Ola Landgren University of Miami
Håkan Mellstedt
Håkan Mellstedt Karolinska Institute
Paul W. Dickman
Paul W. Dickman Karolinska Institute
Lynn R. Goldin
Lynn R. Goldin National Institutes of Health
Anders Österborg
Anders Österborg Karolinska Institute
Bo Nilsson
Bo Nilsson Uppsala University
Gunnar Juliusson
Gunnar Juliusson Lund University
Peter Biberfeld
Peter Biberfeld Karolinska Institute
Anders Ekbom
Anders Ekbom Karolinska Institute
Jan Palmblad
Jan Palmblad Karolinska University Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in healthcare careers beyond traditional medical school, there are a wide range of accessible online programs to consider. Many choose to start their professional journey through nursing, with rn to bsn online programs offering flexibility and cost-effective options for advancing nursing qualifications.

If you have a non-nursing background but wish to enter advanced nursing roles, cheapest direct entry msn programs can offer a direct and affordable pathway to a master's degree in nursing. Admission criteria and competitiveness vary, but students looking for less competitive entry requirements might consider the easiest bsn program to get into.

For those interested in healthcare management, information technology, or administrative careers, medical billing and coding schools that accept fafsa provide a flexible, in-demand career path with crucial financial aid support.

Exploring these online options can lead to rewarding medical and healthcare careers, especially for those seeking flexibility, affordability, and a strong job outlook.

Best Scientists Citing Magnus Björkholm

Trending Scientists

Recently Published Articles